Biomarkers – News and Features

News
Alzheimer’s Vaccine Shows Promise in Animal Studies
An experimental vaccine that blocks Alzheimer's-related tau protein buildup has generated a robust immune response in both mice and non-human primates, building on earlier research.

Article
Phenotypic Screening: A Powerful Tool for Drug Discovery
Phenotypic screening has re-emerged as a powerful strategy for identifying drugs based on their observable effects. Discover how phenotypic screening accelerates drug discovery, supports drug repurposing and enables novel therapeutic breakthroughs.

News
Microglia Engineered Into Living Couriers for Alzheimer's Drugs
Microglia can be engineered to detect disease-specific brain changes – like amyloid plaques in Alzheimer’s disease – and deliver therapeutics exactly where needed.

News
Tumor By-Product Found To Suppress Immune Response
A team of researchers from the University of Chicago, has identified a novel oncometabolite that accumulates in tumors and impairs immune cells’ ability to fight cancer.

News
Researchers Develop RNA Blood Test To Detect Cancers
Stanford Medicine researchers have created a liquid biopsy test capable of detecting cancers, molecular mechanisms of resistance to treatment and tissue injury.

News
Hormone Therapy May Improve Heart Health in Menopausal Women
A study focused on menopausal women found that estrogen-based hormone therapy improved biomarkers associated with cardiovascular health over time. In particular, the study suggests that hormone therapy may lower levels of lipoprotein.

News
Age, Sex and Genetics Affect Blood Biomarkers for Dementia
A long-term study reveals how age, sex, genetics, and menopause influence blood biomarkers related to dementia. The study tracked neurofilament light chain proteins, glial fibrillary acidic proteins, and phosphorylated tau 181.

News
A New Way To Track and Predict Aging
Research has uncovered a new way to measure changes in DNA that predict a person's age.

News
Alzheimer’s Disease Could Be Detected 11 Years Early With New Blood Biomarker
A study identifies beta-synuclein in blood as a potential early biomarker for Alzheimer’s disease. This protein’s levels rise 11 years before cognitive symptoms, offering promise for early diagnosis and improved treatment outcomes.

News
Gene-Based Blood Test for Melanoma Could Spot Early Indicators of Cancer’s Return
Researchers showed that approximately 80 percent of stage 3 melanoma patients who had detectable levels of circulating tumor DNA (ctDNA) before they started treatment to suppress their tumors went on to experience recurrence.
Advertisement